GlassScriptPhysician profile
Catina Greene
NPI 1912443656
$1,867.01
in general payments reported to CMS, 2019-2025
15 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $298 · 2023: $632 · 2024: $431 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,416 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,416.34 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $654.41 | 2022-2025 | |
| Corium, LLC | $258.41 | 2023-2025 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $236.53 | 2022-2024 | Caplyta |
| Axsome Therapeutics, INC. | $191.03 | 2024-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $175.97 | 2021-2023 | Ingrezza |
| Supernus Pharmaceuticals, INC. | $129.52 | 2023-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $36.15 | 2024-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $30.42 | 2024 | |
| Vertical Pharmaceuticals, LLC | $28.47 | 2025 | Relexxii |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 2025 | Cobenfy |
| Janssen Pharmaceuticals, INC | $22.67 | 2023 | Spravato |
| Teva Pharmaceuticals USA, INC. | $21.46 | 2023 | Austedo Xr |
| Collegium Pharmaceutical, INC. | $21.15 | 2025 | Jornay Pm |
| Otsuka America Pharmaceutical, INC. | $18.72 | 2024 | Rexulti |
| Alkermes, INC. | $14.83 | 2024 | Aristada, Lybalvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catina Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.